A physician-supervised plan can help answer whether the medication is appropriate, which option fits the patients risk profile, what dose should be used, how quickly the dose should increase, what side effects should be expected, when the dose should be held or adjusted, how much protein the patient should eat, how muscle can be preserved, what labs should be tracked, and what long-term maintenance should look like
Highlights: Accessible price point Available islandwide Note: Lacks transparency with third party testing
These specialists have extensive experience with dosing protocols, side effect management, and drug interactions based on clinical trial data and post-market surveillance
pmid:37448789 3
Recurrent parathyroid carcinoma and the need for molecular profiling to aid in prognostication and therapeutics
The STEP 4 trial demonstrated that participants who discontinued semaglutide after 20 weeks regained approximately two-thirds of lost weight over the next 48 weeks
